| Dennis Mazal, MD | |
|
19957 Ne 37th Ave, Aventura, FL 33180-3075 | |
| (305) 932-4672 | |
| Not Available |
| Full Name | Dennis Mazal |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Pulmonary Disease |
| Location | 19957 Ne 37th Ave, Aventura, Florida |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447672985 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | ME037384 (Florida) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dennis Mazal, MD 19957 Ne 37th Ave, Aventura, FL 33180-3075 Ph: (305) 932-4672 | Dennis Mazal, MD 19957 Ne 37th Ave, Aventura, FL 33180-3075 Ph: (305) 932-4672 |
News Archive
Democrats and Republicans are preparing for a long political battle that will turn on the ramifications of health reform.
Sorin Group, a global medical device company and a leader in the treatment of cardiovascular diseases, announced today the U.S. commercial launch of the Mitroflow Valsalva Conduit, the only Valsalva conduit graft approved by the U.S. Food and Drug Administration (FDA) for use in combination with an aortic tissue valve.
As the COVID-19 pandemic continues to infect people in their hundreds of thousands around the world, a new study describes a panel of novel tests for genomic (g) and subgenomic (sg) mRNAs generated by SARS-CoV-2. Most assays in use at present are either qualitative or semi-quantitative, and cannot evaluate the transcription molecules in detail.
NMT Medical, Inc. today announced that it has completed a private placement of its common stock and warrants to purchase additional shares of common stock to existing and new stockholders for aggregate proceeds of approximately $5.8 million.
Chronic kidney disease (CKD) affects at least one in four Americans who are older than 60 and can significantly shorten lifespan. Yet the few available drugs for CKD can only modestly delay the disease's progress towards kidney failure. Now, however, a team led by researchers at the Perelman School of Medicine at the University of Pennsylvania, has found an aspect of CKD's development that points to a promising new therapeutic strategy.
› Verified 5 days ago
Mr. Solomon Leo Lerer, M.D., F.A.C.G., Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 21110 Biscayne Blvd, # 303, Aventura, FL 33180 Phone: 305-931-6220 Fax: 305-466-4755 | |
Dr. David Yitzchok Manela, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 2820 Ne 214th St Ste 902, Aventura, FL 33180 Phone: 213-509-5115 | |
Dr. Steven Kobrin, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 2801 Ne 213th St Ste 101, Aventura, FL 33180 Phone: 305-466-7333 Fax: 786-651-2177 | |
Luis Jorge Echarte, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 21110 Biscayne Blvd, Suite 303, Aventura, FL 33180 Phone: 305-466-0030 Fax: 305-466-4755 | |
Nelson Perez Mateu, M.D Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 20601 E Dixie Hwy Ste 340, Aventura, FL 33180 Phone: 786-923-4000 | |
Leonard J Pianko, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 21097 Ne 27th Ct Ste 110, Aventura, FL 33180 Phone: 305-384-4720 Fax: 305-933-1749 | |
Jay E Reinberg, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2845 Aventura Blvd, Suite 247, Aventura, FL 33180 Phone: 305-932-9880 Fax: 305-932-1035 |